U.S. Biotech company CohBar develops mitochondria-based therapeutics for age-related diseases
3 years ago
1.36K
U.S. biotech company CohBar is developing mitochondria-based therapeutics for age-related diseases. One America’s Stephanie Myers spoke with CohBar CEO Steven Engle about the progress and clinical programs they are developing to combat these diseases.
Loading 10 comments...
-
36:19
ryzeconley
6 months agoMoreMito Experience with Adam Oshien & Ryan Conley - Mitochondria Enhancement Technology #AntiAging
27 -
9:41
ryzeconley
6 months agoMoreMito Miracles w/ Susan Connell & Ryan Conley - Mitochondria Enhancement Technology #AntiAging
20 -
29:15
ryzeconley
6 months agoMoreMito Miracles w/ Elta & William & Ryan Conley - Mitochondria Enhancement Technology #AntiAging
51 -
24:15
ryzeconley
6 months ago $0.08 earnedPart 1: Biggest breakthrough in Mitochondria Enhancement Therapy MoreMito - Micah Skye & Ryan Conley
58 -
51:07
ProgressPotentialAndPossibilities
1 year agoDr Brandon Berry, PhD - Exploring Mitochondrial Bioenergetics, Optogenetics, Human Health And Aging
9 -
49:14
Limitless Mindset
1 year agoSKQ1: A smart mitochondrial antioxidant and longevity game changer
2911 -
1:44
KSHB
4 years agoLawrence-based biotech company develops possible COVID-19 therapy
31 -
12:28
LiliasAhmeira
8 months agoHow to Boost Your Mitochondria and Grow Old Disgracefully (Part 2)
136 -
2:40
Uncensored Storm
1 year agoPfizer Acquires Cancer Treatment Biotech Seagen for $43B
7319 -
58:41
aStemCellJourney
9 months agoDr Richard Burt MD Pioneering Hematopoietic Stem Cell Transplants HSCT For Autoimmune Disorders
25